# ppmi-parkinson-s-progression-markers-initiative

> Analysis by Optimly for Optimly AI Visibility, in the Optimly AI Brand Index. Last analyzed August 24, 2026.

> The Parkinson's Progression Markers Initiative (PPMI) is a global, longitudinal observational study designed to identify biomarkers of Parkinson's disease progression. It provides robust, real-time, open-access data to researchers worldwide to accelerate breakthroughs and support validation of new treatments.

- Business Profile: https://optimly.ai/brand/ppmi-parkinson-s-progression-markers-initiative
- Publisher: Optimly (https://optimly.ai)
- Dataset: Optimly AI Brand Index (https://optimly.ai/brand)
- Official website: https://ppmi-info.org/
- Logo: https://logo.clearbit.com/ppmi-info.org
- Slug: ppmi-parkinson-s-progression-markers-initiative
- Category: Real-World Data & Evidence Platforms
- Last Analyzed: August 24, 2026

## Buyer Intent Signals
Problems: Difficulty identifying Parkinson's disease biomarkers | Slow progress in Parkinson's research | Lack of open access data for neurodegenerative diseases | Need for longitudinal patient data in Parkinson's
Solutions: Providing open-access Parkinson's data | Accelerating Parkinson's disease research | Identifying Parkinson's progression markers | Facilitating global collaboration in neurodegenerative studies | Recruiting participants for Parkinson's research studies
Comparisons: Evaluating Parkinson's disease research platforms | Assessing data utility for Parkinson's studies | Comparing neurodegenerative disease initiatives | Reviewing scientific publications on Parkinson's biomarkers